article · Asian Pacific Journal of Cancer Prevention

Immunotherapy and PD-L1 Tumor Expression in Moroccan Non-Small Cell Lung Cancer Patients with Various Metastasis

Oussama Aazzane
Nadia Benchakroun
A Acharki
Sofia Fathi
Meryeme Charkaoui
Hassan Fellah
S. Sahraoui
Mehdi Karkouri

2024Open accessHassan II University Casablanca

Abstract

Our results suggest that tumor expression of PD-L1 and metastatic burden should play a significant role in predicting the response to immunotherapy. Furthermore, it is important to note that the presence of osseous and hepatic metastasis could negatively influence the clinical outcomes of immunotherapy.

Research topics

Cancer Immunotherapy and Biomarkers
Colorectal and Anal Carcinomas
Lung Cancer Treatments and Mutations

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.31557/apjcp.2024.25.8.2841

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.